USDA Labs’ Move to Kansas City Might Be Illegal

An inspector general finds that the agency was supposed to have received congressional approval before relocating facilities out of Washington, DC.

Written byKerry Grens
| 2 min read
usda department of agriculture Economic Research Service National Institute of Food and Agriculture

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK.COM, QINGWA

The US Department of Agriculture should have obtained approval from Congress before deciding to relocate two research facilities from Washington, DC, to Kansas City, a report by the agency’s inspector general finds. The USDA may have violated federal law because the Omnibus Act requires congressional approval before creating, cancelling, or moving a project, according to The Kansas City Star.

The inspector general also determined that the agency didn’t comply with a 60-day deadline to outline to Congress how it would spend $6 million set aside for relocation expenses, Politico reports.

Democratic lawmakers who had asked for the inspector general to investigate oppose the move to Kansas City. “The [USDA] Secretary must follow the will of Congress and refrain from moving forward with the relocation until Congress approves the use of funds for those purposes,” House Majority Leader Steny Hoyer (D-MD) and Delegate Eleanor Holmes Norton (D-DC) ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies